STOCK TITAN

Citius Pharmaceuticals (CTXR) Net Income by Year

CTXR NASDAQ

Citius Pharmaceuticals Inc. reported a net loss of $37.4M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Citius Pharmaceuticals Inc. has filed alongside them.

FY2025 annual
Net Income -$37.4M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CTXR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$37.4Mn/m-$39.1Mn/m-$32.5Mn/m-$33.6Mn/m-$23.1Mn/m-$17.5Mn/m-$15.6Mn/m-$12.5Mn/m-$10.4Mn/m-$8.3Mn/m-$2.9Mn/m-$738Kn/m-$1.3MN/AN/A

CTXR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$8.9Mn/m-$21.2Mn/m-$8.2Mn/mN/A-$8.8Mn/m-$11.5Mn/m-$10.3M-211.4%N/A-$10.6Mn/m-$8.5Mn/m$9.2Mn/mN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Citius Pharmaceuticals Inc. financials

Frequently Asked Questions

What was Citius Pharmaceuticals Inc.'s net income in fiscal year 2025?

Citius Pharmaceuticals Inc. reported a net loss of $37.4M in fiscal year 2025.

How fast is Citius Pharmaceuticals Inc.'s net income growing?

Citius Pharmaceuticals Inc. (CTXR) reported a $39.1M net loss in fiscal year 2024 and a $37.4M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What was Citius Pharmaceuticals Inc.'s net income in the most recent quarter?

Citius Pharmaceuticals Inc. (CTXR) reported -$8.9M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Citius Pharmaceuticals Inc. (CTXR) reported on that line in every period on record.